Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Tandem Diabetes Care planning a 5.25-million-share offering worth $60 million for its line of insulin pumps
Tandem Diabetes Care planning a 5.25-million-share offering worth $60 million for its line of insulin pumps
Tandem Diabetes Care planning a 5.25-million-share offering worth $60 million for its line of insulin pumps
Submitted by
admin
on March 2, 2015 - 9:23am
Source:
Mass Device
News Tags:
Tandem Diabetes
diabetes
devices
insulin pumps
Headline:
Tandem Diabetes Care planning a 5.25-million-share offering worth $60 million for its line of insulin pumps
Do Not Allow Advertisers to Use My Personal information
